These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6230454)

  • 21. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
    Danis VA; Heatley RV
    Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
    Elson CO; James SP; Graeff AS; Berendson RA; Strober W
    Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
    Fujita K; Okabe N; Yao T
    J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients.
    Braun DP; Harris ZL; Harris JE; Sandler S; Khandekar J; Locker G; Haid M; Gordon L; Shaw J; Cobleigh M
    J Biol Response Mod; 1983; 2(3):251-62. PubMed ID: 6196453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
    Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
    J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
    Ginsburg CH; Falchuk ZM
    Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals.
    Victorino RM; Hodgson HJ
    Clin Exp Immunol; 1980 Dec; 42(3):571-8. PubMed ID: 6452237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
    Iwao Y; Hibi T; Watanabe M; Takaishi H; Hosoda Y; Hayashi A; Ohara M; Ogata H; Aiso S; Toda K
    J Clin Lab Immunol; 1992; 38(1):15-27. PubMed ID: 1343345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB; Balch CM
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating lymphocyte subpopulations in Crohn's disease.
    Yuan SZ; Hanauer SB; Kluskens LF; Kraft SC
    Gastroenterology; 1983 Dec; 85(6):1313-8. PubMed ID: 6605274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of B suppressor cells by phytohaemagglutinin.
    Farkas R; Manor Y; Klajman A
    Immunology; 1986 Mar; 57(3):395-8. PubMed ID: 2937719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulatory abnormalities in chronic lymphocytic leukemia. I. Correlations of immunoregulatory subpopulations with stage of disease.
    Keller RH; Blake DG; Lyman S; Siebenlist R
    J Clin Lab Immunol; 1981 Nov; 6(3):201-9. PubMed ID: 6461766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
    Goodwin JS; Messner RP; Peake GT
    J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
    Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
    Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
    Smith MD; Hardy G; Williams JD; Coles GA
    Clin Nephrol; 1983 Sep; 20(3):130-5. PubMed ID: 6226465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor cells and survival of patients with advanced gastric cancer.
    Zembala M; Mytar B; Ruggiero I; Uracz W; Popiela T; Czupryna A
    J Natl Cancer Inst; 1983 Feb; 70(2):223-8. PubMed ID: 6218331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cell regulation of cell-mediated immune responses in renal infection in vitro modulation of suppressor cell activity.
    Miller T; Marshall E
    J Clin Invest; 1980 Oct; 66(4):621-8. PubMed ID: 6448267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.